ArticlePharmacology research & perspectives2023

Effect of nivasorexant (ACT-539313), a selective orexin-1-receptor antagonist, on multiple cytochrome P450 probe substrates in vitro and in vivo using a cocktail approach in healthy subjects.

Benjamin Berger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.